Low-density lipoprotein apheresis: an overview.
Bambauer R, Schiel R, Latza R.
Ther Apher Dial. 2003 Aug;7(4):382-90. doi: 10.1046/j.1526-0968.2003.00070.x.
Low-density-lipoprotein apheresis.
Olbricht CJ.
Lancet. 1995 Jul 8;346(8967):116; author reply 117.
Low-density-lipoprotein apheresis.
Richter WO, Schwandt P.
Lancet. 1995 Jul 8;346(8967):116-7.
The role of low density lipoprotein apheresis in the treatment of familial hypercholesterolemia.
Thompson GR, Kitano Y.
Ther Apher. 1997 Feb;1(1):13-6. doi: 10.1111/j.1744-9987.1997.tb00006.x.
Low density lipoprotein (LDL) binding affinity for the LDL receptor in hyperlipoproteinemia.
Toyota Y, Yamamura T, Miyake Y, Yamamoto A.
Atherosclerosis. 1999 Nov 1;147(1):77-86. doi: 10.1016/s0021-9150(99)00166-5.
Low density lipoprotein apheresis: a selective plasma separation method.
Bambauer R.
Artif Organs. 1996 Apr;20(4):284-5. doi: 10.1111/j.1525-1594.1996.tb04445.x.
Expression of LDLRs (Low-Density Lipoprotein Receptors), Dyslipidemia Severity, and Response to PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Inhibition in Homozygous Familial Hypercholesterolemia: Connecting the Dots.
Santos RD.
Arterioscler Thromb Vasc Biol. 2018 Mar;38(3):481-483. doi: 10.1161/ATVBAHA.117.310675.
Receptor-Independent Transfer of Low Density Lipoprotein Cargo to Biomembranes.
Axmann M, Sezgin E, Karner A, Novacek J, Brodesser MD, Röhrl C, Preiner J, Stangl H, Plochberger B.
Nano Lett. 2019 Apr 10;19(4):2562-2567. doi: 10.1021/acs.nanolett.9b00319. Epub 2019 Mar 8.
Very low density lipoprotein apolipoprotein B metabolism in humans.
Demant T, Shepherd J, Packard CJ.
Klin Wochenschr. 1988 Aug 15;66(16):703-12. doi: 10.1007/BF01726412.
Low-density lipoprotein receptor mutational analysis in diagnosis of familial hypercholesterolemia.
Bourbon M, Alves AC, Sijbrands EJ.
Curr Opin Lipidol. 2017 Apr;28(2):120-129. doi: 10.1097/MOL.0000000000000404.
